Standard BioTools Return on Tangible Equity 2010-2024 | LAB

Current and historical return on tangible equity values for Standard BioTools (LAB) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Standard BioTools Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-06-30 $-0.17B $0.38B -69.47%
2024-03-31 $-0.14B $0.45B -83.05%
2023-12-31 $-0.08B $0.06B -97.72%
2023-09-30 $-0.08B $0.07B -83.75%
2023-06-30 $-0.08B $0.09B -79.81%
2023-03-31 $-0.13B $0.10B -108.04%
2022-12-31 $-0.19B $0.11B -273.38%
2022-09-30 $-0.18B $0.13B -560.63%
2022-06-30 $-0.16B $0.15B 1715.79%
2022-03-31 $-0.12B $-0.11B 212.84%
2021-12-31 $-0.06B $-0.04B 181.54%
2021-09-30 $-0.07B $-0.04B 277.55%
2021-06-30 $-0.06B $-0.03B 421.05%
2021-03-31 $-0.06B $-0.02B 497.78%
2020-12-31 $-0.05B $-0.01B 572.97%
2020-09-30 $-0.05B $0.00B 738.46%
2020-06-30 $-0.06B $-0.02B 1100.00%
2020-03-31 $-0.06B $-0.01B -1400.00%
2019-12-31 $-0.07B $0.00B -490.57%
2019-09-30 $-0.07B $0.01B 687.18%
2019-06-30 $-0.07B $0.02B 145.26%
2019-03-31 $-0.07B $0.02B 83.78%
2018-12-31 $-0.06B $-0.09B 48.76%
2018-09-30 $-0.05B $-0.14B 40.22%
2018-06-30 $-0.06B $-0.13B 41.43%
2018-03-31 $-0.06B $-0.12B 40.51%
2017-12-31 $-0.06B $-0.14B 41.74%
2017-09-30 $-0.07B $-0.14B 48.23%
2017-06-30 $-0.07B $-0.15B 52.65%
2017-03-31 $-0.07B $-0.14B 59.44%
2016-12-31 $-0.08B $-0.13B 68.75%
2016-09-30 $-0.07B $-0.12B 72.54%
2016-06-30 $-0.06B $-0.11B 69.32%
2016-03-31 $-0.06B $-0.09B 72.61%
2015-12-31 $-0.05B $-0.08B 75.18%
2015-09-30 $-0.05B $-0.07B 79.07%
2015-06-30 $-0.06B $-0.07B 93.72%
2015-03-31 $-0.05B $-0.06B 97.30%
2014-12-31 $-0.05B $-0.06B 101.92%
2014-09-30 $-0.05B $-0.06B 335.71%
2014-06-30 $-0.04B $-0.05B -154.17%
2014-03-31 $-0.03B $-0.05B -45.90%
2013-12-31 $-0.02B $0.10B -17.39%
2013-09-30 $-0.02B $0.10B -16.16%
2013-06-30 $-0.02B $0.10B -15.92%
2013-03-31 $-0.02B $0.10B -19.26%
2012-12-31 $-0.02B $0.10B -26.23%
2012-09-30 $-0.02B $0.10B -29.12%
2012-06-30 $-0.02B $0.05B -35.02%
2012-03-31 $-0.02B $0.05B -36.52%
2011-12-31 $-0.03B $0.06B -50.20%
2011-09-30 $-0.03B $0.06B -12400.00%
2011-06-30 $-0.03B $0.06B 200.00%
2011-03-31 $-0.03B $0.07B 91.80%
2010-12-31 $-0.02B $-0.19B 35.60%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.830B $0.106B
Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $11.978B 0.00
Inspire Medical Systems (INSP) United States $6.055B 188.82
Hims & Hers Health (HIMS) United States $5.988B 154.89
Axonics (AXNX) United States $3.602B 1762.00
IRhythm Technologies (IRTC) United States $2.783B 0.00
Privia Health (PRVA) United States $2.736B 228.00
Enovis (ENOV) United States $2.646B 17.94
Omnicell (OMCL) United States $2.263B 74.03
Azenta (AZTA) United States $2.242B 127.33
10x Genomics (TXG) United States $1.925B 0.00
Clover Health Investments (CLOV) United States $1.657B 0.00
Schrodinger (SDGR) United States $1.422B 0.00
Phreesia (PHR) United States $1.252B 0.00
Fulgent Genetics (FLGT) United States $0.613B 0.00
Talkspace (TALK) United States $0.586B 0.00
Butterfly Network (BFLY) United States $0.582B 0.00
Definitive Healthcare (DH) United States $0.508B 88.00
Health Catalyst (HCAT) United States $0.506B 0.00
Pulmonx (LUNG) United States $0.298B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.248B 0.00
TruBridge (TBRG) United States $0.214B 62.22
P3 Health Partners (PIII) United States $0.142B 0.00
American Well (AMWL) United States $0.139B 0.00
EUDA Health Holdings (EUDA) Singapore $0.106B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.064B 0.00
111 (YI) China $0.057B 0.00
Zepp Health (ZEPP) China $0.050B 0.00
Outset Medical (OM) United States $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
CareCloud (CCLD) United States $0.042B 0.00
Movano (MOVE) United States $0.028B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
MSP Recovery (LIFW) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00